Document Detail


Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.
MedLine Citation:
PMID:  10455409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this article, we investigated the effect induced by the reintroduction of wild-type p53 (wt-p53) protein on BCNU sensitivity in the ADF glioblastoma line. Using a wt-p53 recombinant adenovirus (Ad-p53), we demonstrated that exogenous wt-p53 expression was able to increase the sensitivity to BCNU in ADF cells. Interestingly, this effect was more evident when Ad-p53 infection was performed after BCNU treatment compared with the opposite sequence. To understand the biological basis of these different behaviors, we analyzed the cell cycle of the differently treated cells. We found that Ad-p53 infection induced a persistent accumulation of cells in the G0/G1 phase while, as expected, BCNU induced a block in the G2-M phase. Ad-p53-->BCNU sequence did not significantly modify the cell cycle profile in respect of Ad-p53 infected cells. In contrast, BCNU-->Ad-p53 sequence provoked G2-M arrest similar to that observed after treatment with BCNU alone, but prevented the later recovery of the cells through the cell cycle, by driving the cells to apoptotic death. These results demonstrate that the administration sequence is important to increase drug sensitivity. To generalize the phenomenon observed on ADF line, the antiproliferative effect of the two different schedules was analyzed on other glioblastoma lines (A172, CRS-A2, U373MG) with different BCNU sensitivity and p53 status. The data obtained confirm that the wt-p53 gene transfer enhances BCNU sensitivity in glioblastoma cells depending on the administration sequence.
Authors:
A Biroccio; D D Bufalo; A Ricca; C D'Angelo; G D'Orazi; A Sacchi; S Soddu; G Zupi
Related Documents :
11129739 - Topoisomerase i inhibitor (camptothecin)-induced apoptosis in human gastric cancer cell...
9488309 - Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration...
12573569 - The htlv-1 tax oncoprotein attenuates dna damage induced g1 arrest and enhances apoptos...
16211279 - E1b-deleted adenovirus replicates in p53-deficient lung cancer cells due to the absence...
17611669 - Hsp72 controls bortezomib-induced hepg2 cell death via interaction with pro-apoptotic f...
20515749 - P53 as the main traffic controller of the cell signaling network.
19947919 - Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, rh...
24688409 - Effects of thapsigargin on the proliferation and survival of human rheumatoid arthritis...
8025349 - The importance of blood cell-vessel wall interactions in tumour metastasis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gene therapy     Volume:  6     ISSN:  0969-7128     ISO Abbreviation:  Gene Ther.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  2000-02-24     Completed Date:  2000-02-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421525     Medline TA:  Gene Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1064-72     Citation Subset:  IM    
Affiliation:
Experimental Chemotherapy Laboratory, Regina Elena Cancer Institute, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoviridae
Antineoplastic Agents, Alkylating / therapeutic use*
Brain Neoplasms / therapy*
Carmustine / therapeutic use*
Drug Administration Schedule
Drug Resistance, Neoplasm
Gene Therapy / methods*
Genes, p53 / genetics
Glioblastoma / therapy*
Humans
Tumor Cells, Cultured
Tumor Suppressor Protein p53 / genetics*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 0/Tumor Suppressor Protein p53; 154-93-8/Carmustine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high mu...
Next Document:  Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene t...